Loading clinical trials...
Loading clinical trials...
VAV00039 is a first-in-human (FiH) study to assess the safety and immunogenicity (in adult participants aged 60-75 years) after a single injection of different dose formulations of an RSV/hMPV vaccine...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
NCT06597916 · RSV Infection
NCT05765396 · COVID-19, SARS-CoV-2 Virus, and more
NCT07482657 · RSV Infection, RSV, and more
NCT03596801 · RSV Infection
NCT04520659 · RSV Infection
Site # 0361004
Botany, New South Wales
Site # 031001
Brookvale, New South Wales
Site # 0361006
Miranda, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions